- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| JIN MEDICAL INTERNATIONAL Aktie jetzt für 0€ handeln | |||||
| 11.10. | Jin Medical International Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 10.10. | Jin Medical International Ltd.: Construction of JinMed's New Facility Begins in Chuzhou, China | 4 | GlobeNewswire (USA) | ||
| 23.09. | Jin Medical International, Nio And Other Big Stocks Moving Lower In Monday's Pre-Market Session | 30 | Benzinga.com | ||
| 26.07. | Jin Medical International Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 19.12.23 | Pre-market Movers: Infobird, Jin Medical International, Motus GI, Panbela Therapeutics, Shengfeng Development | 1.035 | AFX News | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 07.10 A.M. ET).In the Green Infobird Co., Ltd (IFBD) is up over 80% at $2.44.
Jin... ► Artikel lesen | |
| 14.12.23 | Jin Medical International Ltd. Enters into Memorandum of Understanding to Acquire Medical Equipment Sharing Platform | 386 | GlobeNewswire (Europe) | Changzhou City, China, Dec. 14, 2023 (GLOBE NEWSWIRE) -- JIN MEDICAL INTERNATIONAL LTD. (the "Company" or "JinMed") (NASDAQ: ZJYL), a Cayman Islands holding company with Chinese operating entities that... ► Artikel lesen |
6 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 1,154 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights | Obtained agreement from FDA to initiate a Phase 1 trial evaluating multiple doses of Rhenium (186Re) Obisbemeda for the treatment of patients with leptomeningeal metastases (LM) Presented positive... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 1,158 | +2,12 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Five Abstracts Highlighting (Z)-Endoxifen Research Accepted for Presentation at the 2024 San Antonio Breast Cancer Symposium | SEATTLE, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical stage biopharmaceutical company developing innovative medicines in areas... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,010 | +2,02 % | Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results | SALT LAKE CITY, Nov. 7, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
| ASENSUS SURGICAL | 0,305 | 0,00 % | KARL STORZ akquiriert den US-amerikanischen Robotik-Spezialisten Asensus Surgical | Tuttlingen / Research Triangle Park, USA (ots) - Das familiengeführte und international agierende Medizintechnikunternehmen KARL STORZ gibt die Akquisition des innovativen Robotik-Spezialisten Asensus... ► Artikel lesen | |
| EMEIS | 5,705 | +1,44 % | emeis: Upturn in Performance Confirmed in Third-Quarter 2024 | Revenue up +8.3%, occupancy rate up +2.6 points
Regulatory News:
emeis (Paris:EMEIS):
Growth in all core activities and in all geographical areas (revenue and occupancy rate)
Solid... ► Artikel lesen | |
| AMBU | 15,025 | 0,00 % | NASDAQ OMX Nordic: Stressed market conditions in derivatives on AMBU (304/24) | Nasdaq has decided to call for stressed market conditions in derivatives on
Ambu AS (AMBU) for four hours, after which time an assessment of market
conditions will be made to determine if stressed market... ► Artikel lesen | |
| EKSO BIONICS | 0,710 | +5,34 % | Ekso Bionics stock plunges to 52-week low of $0.71 | ||
| NANO-X IMAGING | 5,890 | 0,00 % | Nano-X Imaging LTD.: Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium | HealthCCSng V2.0 introduces additional 'zero calcium' categorization of coronary artery calcium (CAC) and generates a numerical calcium score with corresponding CAC detection category output Marks... ► Artikel lesen | |
| NOVACYT | 0,584 | +0,34 % | Novacyt S.A. - Further expansion of cost reduction programme | ||
| BUTTERFLY NETWORK | 3,325 | 0,00 % | BFLY-Aktie erreicht 52-Wochen-Hoch bei 2,95 US-Dollar | ||
| AETHLON MEDICAL | 0,328 | 0,00 % | AETHLON MEDICAL INC - S-8, Securities to be offered to employees in employee benefit plans | ||
| GOODRX | 4,310 | 0,00 % | GoodRx Holdings one of the most undervalued stocks, Leerink says | ||
| TALKSPACE | 3,160 | 0,00 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
| CARMAT | 1,190 | -1,00 % | CARMAT's Aeson Artificial Heart Is Gradually Becoming a Reference Solution for Bridge to Transplant in Europe | Milestone of 30 heart transplants post Aeson® support, passed Strong interest in Aeson® from the medical community: more than 100 European experts will share their experience at the first... ► Artikel lesen | |
| JOINT CORP | 11,310 | 0,00 % | JYNT's Q3 Earnings Meet Estimates Amid Higher Costs, Shares Dip 3% |
JIN MEDICAL INTERNATIONAL LTD gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,999 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu JIN MEDICAL INTERNATIONAL LTD finden Sie auf Wallstreet Online.
